IV Pain Medications for Severe Sciatica
For severe sciatica requiring IV analgesia, use IV ketorolac 15 mg every 6 hours (maximum 5 days) as first-line therapy, or IV morphine 0.1-0.2 mg/kg every 4 hours if ketorolac is contraindicated or inadequate. 1, 2, 3
First-Line IV Therapy: Ketorolac
Ketorolac is the preferred IV NSAID for acute severe pain when oral medications have failed or cannot be tolerated. 1, 2
Dosing Protocol
- Adults 17-64 years: 15-30 mg IV every 6 hours, maximum 120 mg/day 1, 2
- Adults ≥65 years, renally impaired, or <50 kg: 15 mg IV every 6 hours only 2
- Maximum duration: 5 days total 1, 2
- Lower doses (7.5-15 mg) provide equivalent analgesia to higher doses (30 mg) with better safety profile 4, 5
Critical Contraindications
Ketorolac is absolutely contraindicated in patients with: 1, 2
- Active or history of peptic ulcer disease or GI bleeding
- Age >60 years with significant alcohol use or hepatic dysfunction
- Compromised fluid status, dehydration, or renal insufficiency
- Thrombocytopenia or concurrent anticoagulant/antiplatelet therapy
- Aspirin/NSAID-induced asthma
- Cerebrovascular bleeding or high cardiovascular risk
Mandatory Monitoring
Before initiating ketorolac, obtain baseline: 1, 2
- Blood pressure, BUN, creatinine
- Liver function tests (alkaline phosphatase, LDH, SGOT, SGPT)
- Complete blood count
- Fecal occult blood
Discontinue immediately if: 1, 2
- BUN or creatinine doubles
- Hypertension develops or worsens
- Liver function tests increase >3× upper limit of normal
- Any signs of GI bleeding
Clinical Limitations
- Onset of action is delayed 30-60 minutes 1, 6
- >25% of patients exhibit little or no analgesic response 6
- Most useful as adjunct to opioids rather than monotherapy for severe pain 6, 4
Second-Line IV Therapy: Morphine
When ketorolac is contraindicated or provides inadequate relief, IV morphine is the standard opioid for severe sciatica. 3
Dosing Protocol
- Initial dose: 0.1-0.2 mg/kg IV every 4 hours as needed 3
- Adjust based on pain severity, adverse events, patient age, and size 3
- Rapid IV administration may cause chest wall rigidity 3
Critical Warnings
- Respiratory depression is the most serious adverse reaction 3
- High doses may cause sympathetic hyperactivity, increased catecholamines, and convulsions 3
- May cause hypotension in ambulatory patients 3
- Contraindicated in bronchial asthma, upper airway obstruction, and paralytic ileus 3
Drug Interactions
- CNS depressants increase risk of respiratory depression, hypotension, sedation, or death 3
- Muscle relaxants may enhance neuromuscular blockade and cause respiratory depression 3
- Anticholinergics increase risk of urinary retention and severe constipation 3
Adjunctive Therapy for Neuropathic Component
Sciatica is a mixed pain syndrome with both nociceptive and neuropathic components; IV analgesics alone may be insufficient. 7
Add Gabapentinoids for Neuropathic Pain
Once acute pain is controlled with IV medications, transition to oral adjuvants: 1
- Gabapentin: Start 100-200 mg/day, titrate to 900-3600 mg/day in divided doses 1
- Pregabalin: Start 25-50 mg/day, titrate to 150-600 mg/day in two divided doses 1
- Evidence supports gabapentin for radiculopathy with fair quality 1
Alternative IV NSAID Options
If ketorolac is unavailable but IV NSAID therapy is appropriate:
- Ibuprofen: 400-800 mg IV every 6 hours, maximum 3200 mg/day 1, 8
- Never combine ketorolac with other NSAIDs - toxicities are additive without additional analgesic benefit 2
Critical Clinical Pitfalls
Common Errors to Avoid
- Do not use systemic corticosteroids - good evidence shows they are ineffective for sciatica 1
- Do not exceed 5-day duration for ketorolac - risk-benefit ratio deteriorates significantly with prolonged use 1, 2
- Do not use ketorolac as monotherapy for severe pain - it works best as adjunct to opioids 6, 4
- Do not assume all patients respond to ketorolac - >25% show minimal response 6
Transition Planning
- Begin oral medications before discontinuing IV therapy to prevent pain recurrence 1
- If pain persists beyond acute phase, investigate for underlying treatable causes rather than continuing IV analgesics 8
- Consider multimodal approach combining NSAIDs, gabapentinoids, and physical modalities for chronic symptoms 1